Ioana Zachia-Zlatea

Ms. Ioana Zachia-Zlatea

Doctoral School of Urbanism, Ion Mincu University of Architecture and Urbanism, Bucharest, Bucureşti, Romania
+1
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
Diana Antonia CosteaDiana Antonia Costea
Diana Antonia Costea
Valentina-Alexandra BadalutaValentina-Alexandra Badaluta
Valentina-Alexandra Badaluta
IZIoana Zachia-Zlatea
Ioana Zachia-Zlatea
Alina Maria HolbanAlina Maria Holban
Alina Maria Holban
Lia-Mara DituLia-Mara Ditu
Lia-Mara Ditu
Veronica LazarVeronica Lazar
Veronica Lazar
Biofilms are structured communities of microorganisms embedded in a self-produced extracellular polymeric substance (EPS) matrix, whose development significantly enhances microbial resistance to antibiotics, disinfectants, and host immune defenses, posing major challenges in clinical, industrial, and environmental settings. Compared with planktonic cells, biofilm-associated microorganisms can exhibit up to 10- to 1000-fold increased tolerance to antimicrobial agents, contributing to the persistence of biofilm-associated infections (BAIs). These infections remain difficult to eradicate due to reduced penetration, altered metabolic states, and the presence of dormant or persister cells. Anti-biofilm strategies can be broadly classified into physical approaches (e.g., ultrasound, mechanical stress, and light-based approaches) that target biofilm structure; chemical and enzymatic methods (e.g., EPS-degrading enzymes) that destabilize the matrix; and biological and molecular strategies (e.g., quorum-sensing (QS) inhibitors, anti-virulence agents, bacteriophages, phage-derived antimicrobial molecules, antimicrobial peptides, and natural bioactive compounds) that modulate biofilm development and integrity by targeting regulatory pathways and matrix stability through distinct mechanisms of action. Natural compounds, including lactoferrin, lactoferrin-derived peptides, and probiotic and postbiotic fractions of lactic acid bacteria (LAB), as well as plant-derived metabolites, have shown promising anti-biofilm effects, with efficacy often enhanced through complementary or potentially synergistic interactions. However, despite these advancements, clinical translation remains limited. For example, BAIs account for approximately 80% of chronic infections, with high recurrence rates and therapeutic failure reported in device-associated infections and chronic wounds. These limitations highlight the need for clinically translatable, multimodal approaches that integrate structural biofilm disruption, antimicrobial targeting, and host response modulation to design more effective and sustainable anti-biofilm strategies.

4 November 2026 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
VBValentina-Alexandra Badaluta
Valentina-Alexandra Badaluta
IZIoana Zachia-Zlatea
Ioana Zachia-Zlatea
Diana Antonia CosteaDiana Antonia Costea
Diana Antonia Costea
APAlexandru-Ionut Petrisor
Alexandru-Ionut Petrisor
AHAlina-Maria Holban
Alina-Maria Holban
VLVeronica Lazar
Veronica Lazar
Understanding how biofilms came to be recognized as spatially organized, three-dimensional (3D) communities (rather than isolated planktonic cells) requires tracing the conceptual shift that redefined bacterial life as architecturally structured. Biofilms, defined as surface-attached communities of microbial cells, represent the dominant mode of life for microorganisms, creating favorable microenvironments for their constituent cells that promote antimicrobial tolerance and persistence, ultimately contributing to the emergence of antimicrobial resistance (AMR). This review examines how the structural organization and phenotypic plasticity of biofilms generate preconditions that enable antimicrobial tolerance in biofilm-incorporated cells, thereby contributing to the amplification of AMR. To integrate these dimensions, this review proposes a framework comprising five interconnected and overlapping categories of biofilm resilience mechanisms: physical, chemical, physiological, social, and genetic.Physical resilience arises from the 3D organization of the extracellular matrix, which creates a protective physico-chemical environment that limits the penetration of antimicrobials and immune clearance. Properties such as matrix viscoelasticity further enable biofilms to withstand and recover from mechanical stress. Chemical resilience is mediated by degradative enzymes that inactivate antimicrobial compounds, as well as by efflux pumps and oxidative-stress neutralization.Physiological resilience arises from community heterogeneity and metabolic latency, including dormant or persister cells. Social resilience involves metabolic cooperation, cross-feeding, cross-protection, and collective coordination through quorum sensing (QS).Genetic resilience involves adaptive gene-expression changes, stress-associated hypermutability, enhanced acquisition of antimicrobial resistance genes (ARGs) through horizontal gene transfer (HGT), which, together with biofilm-associated tolerance, create conditions that facilitate the emergence and dissemination of AMR. Collectively, these features support the conceptualization of biofilms as organized microbial systems, or “citadels”, capable of collective defense and long-term persistence. In this context, biofilms have emerged as programmed survival systems in which architecture drives selection, persistence, and resistance evolution. Key questions remain regarding how biofilm microenvironments modulate the balance between reversible antimicrobial tolerance and stable genetic resistance.